Sequential Deletion of the Integrase (Gag-Pol) Carboxyl Terminus Reveals Distinct Phenotypic Classes of Defective HIV-1
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
A requisite step in the life cycle of human immunodeficiency virus type 1 (HIV-1) is the insertion of the viral genome into that of the host cell, a process catalyzed by the 288-amino-acid (32-kDa) viral integrase (IN). IN recognizes and cleaves the ends of reverse-transcribed viral DNA and directs its insertion into the chromosomal DNA of the target cell. IN function, however, is not limited to integration, as the protein is required for other aspects of viral replication, including assembly, virion maturation, and reverse transcription. Previous studies demonstrated that IN is comprised of three domains: the N-terminal domain (NTD), catalytic core domain (CCD), and C-terminal domain (CTD). Whereas the CCD is mainly responsible for providing the structural framework for catalysis, the roles of the other two domains remain enigmatic. This study aimed to elucidate the primary and subsidiary roles that the CTD has in protein function. To this end, we generated and tested a nested set of IN C-terminal deletion mutants in measurable assays of virologic function. We discovered that removal of up to 15 residues (IN 273) resulted in incremental diminution of enzymatic function and infectivity and that removal of the next three residues resulted in a loss of infectivity. However, replication competency was surprisingly reestablished with one further truncation, corresponding to IN 269 and coinciding with partial restoration of integration activity, but it was lost permanently for all truncations extending N terminal to this position. Our analyses of these replication-competent and -incompetent truncation mutants suggest potential roles for the IN CTD in precursor protein processing, reverse transcription, integration, and IN multimerization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At least in some cases, the class II phenotype was accompanied by premature proteolytic maturation, misfolding or perhaps mislocalisation of the mutant Gag-Pol polyprotein130,135,136.”
From Structure and function of retroviral integrase (2022) · cites this paper as [135]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“normalized for protein content (5), and 25 g protein (intracellular) or 15 g”
BackgroundIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977 · cited 3×
“cation of the twin-PCR amplification protocol designed by Chun et al (16),”
MethodInfluentialInhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131 · cited 1×
“The biochemical mechanisms that lead to retroviral integration, which have been extensively studied in vitro, are defined by two catalytically related and sequentially dependent steps (18) which may be distinguished by their respective sensitivities to current inhibitors of IN function (39).”
BackgroundIn Vivo Footprinting of a Muscle Specific Enhancer by Ligation Mediated PCR
Mueller, P. R., & Wold, B. (1989) · Science · doi:10.1126/science.2814500 · Cited by 944 · cited 1×
“ligation-mediated (62) quantitative PCR (LMqPCR) assay for 3 processing is”
MethodDyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 1×
“The structural data show that the isoleucine residue at position 268 is the last residue of the fifth and final -sheet (residues 265 to 268) of the SH3 fold (13, 22, 23).”
BackgroundRetroviral intasome assembly and inhibition of DNA strand transfer
Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature08784 · Cited by 678 · cited 3×
“Cross-linking (32, 42) and complementation (25, 73) studies of HIV-1 IN support a model in which the CTD of one subunit (analogous to the unresolved CTD of an outer PFV intasome subunit) binds subterminal viral LTR DNA, stabilizing the viral DNA terminus in the active site of the opposing subunit (the inner PFV intaso…”
BackgroundChesebro, B., Wehrly, K., Nishio, J., & Perryman, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6547-6554.1992 · Cited by 585 · cited 1×
“minus of IN (6G5) (65), capsid (CA) (183-H12-5C) (14), or RT (11B7 and 33D5)”
Kulkosky, J., Jones, K. S., Katz, R. A., Mack, J. P., & Skalka, A. M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2331 · Cited by 571 · cited 1×
“Mutation of any of these residues abrogates the catalytic functions of IN both in vitro (21, 26, 46, 72) and in the context of viral replication (27, 47, 78), and the mutant viruses thus elicited are characterized as paradigmatic class I mutants.”
BackgroundEngelman, A., & Craigie, R. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6361-6369.1992 · Cited by 519 · cited 2×
“Mutation of any of these residues abrogates the catalytic functions of IN both in vitro (21, 26, 46, 72) and in the context of viral replication (27, 47, 78), and the mutant viruses thus elicited are characterized as paradigmatic class I mutants.”
BackgroundMethodHu, W.-S., & Hughes, S. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006882 · Cited by 505
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication
Engelman, A., Englund, G., Orenstein, J. M., Martin, M. A., & Craigie, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2729-2736.1995 · Cited by 445 · cited 1×
“Mutation of any of these residues abrogates the catalytic functions of IN both in vitro (21, 26, 46, 72) and in the context of viral replication (27, 47, 78), and the mutant viruses thus elicited are characterized as paradigmatic class I mutants.”
BackgroundChen, J. C.-H., Krucinski, J., Miercke, L. J. W., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150220297 · Cited by 404 · cited 2×
“The crystal structure of a two-domain HIV-1 IN CCDCTD fragment (12) reveals a Y-shaped dimer formed via a CCD-CCD interface that is also conserved between the CCDs of the inner and outer subunits of the PFV intasome (13, 36, FIG.”
BackgroundHIV-1 Reverse Transcription A Termination Step at the Center of the Genome
Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H., & Clavel, F. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1542 · Cited by 388 · cited 3×
“HEK293T, GHOST(3)X4/R5 (60), and HeLaP4R5 (11) cells were cultured in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 100 U/ml penicillin–100 g/ml streptomycin (P/S); CEM cells were cultured in RPMI 1640 supplemented with 10% FCS and P/S. Viral stocks were generated in one of two…”
MethodThree new structures of the core domain of HIV-1 integrase: An active site that binds magnesium
Goldgur, Y., Dyda, F., Hickman, A. B., Jenkins, T. M., Craigie, R., & Davies, D. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9150 · Cited by 380
A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons
Tasaki, T., Mulder, L. C. F., Iwamatsu, A., Lee, M. J., Davydov, I. V., Varshavsky, A., Muesing, M., & Kwon, Y. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7120-7136.2005 · Cited by 354
Self-citationEngelman, A., Bushman, F. D., & Craigie, R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05996.x · Cited by 350 · cited 2×
“Cross-linking (32, 42) and complementation (25, 73) studies of HIV-1 IN support a model in which the CTD of one subunit (analogous to the unresolved CTD of an outer PFV intasome subunit) binds subterminal viral LTR DNA, stabilizing the viral DNA terminus in the active site of the opposing subunit (the inner PFV intaso…”
BackgroundMethodSolution structure of the N-terminal zinc binding domain of HIV-1 integrase
Cai, M., Zheng, R., Caffrey, M., Craigie, R., Clore, G. M., & Gronenborn, A. M. (1997) · Nature Structural Biology · doi:10.1038/nsb0797-567 · Cited by 342
Zheng, R., Jenkins, T. M., & Craigie, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13659 · Cited by 341 · cited 2×
“This motif is requisite for proper NTD folding and IN multimerization and contributes to integrase-mediated catalytic activity (81).”
BackgroundWang, J.-Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7333 · Cited by 335
Mörner, A., Björndal, Å., Albert, J., KewalRamani, V. N., Littman, D. R., Inoue, R., Thorstensson, R., Fenyö, E. M., & Björling, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2343-2349.1999 · Cited by 328
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305 · cited 1×
“Though PFV and HIV-1 are divergent members of the retroviral family lineage, HIV-1 strand transfer inhibitors also inhibit PFV IN (37), suggesting that similar catalytic mechanisms are employed by these INs (13, 36, 45).”
BackgroundSolution Structure of the DNA Binding Domain of HIV-1 Integrase
Lodi, P. J., Ernst, J. A., Kuszewski, J., Hickman, A. B., Engelman, A., Craigie, R., Clore, G. M., & Gronenborn, A. M. (1995) · Biochemistry · doi:10.1021/bi00031a002 · Cited by 300
The mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296 · cited 4×
“Cross-linking (32, 42) and complementation (25, 73) studies of HIV-1 IN support a model in which the CTD of one subunit (analogous to the unresolved CTD of an outer PFV intasome subunit) binds subterminal viral LTR DNA, stabilizing the viral DNA terminus in the active site of the opposing subunit (the inner PFV intaso…”
BackgroundInfluentialWiskerchen, M., & Muesing, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.376-386.1995 · Cited by 273 · cited 3×
“It has been established by previous research that successful ongoing viral replication in culture is contingent on an integration rate of at least 10 to 15% of that of the wild-type virus (78).”
BackgroundSelf-citationEsposito, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5832 · Cited by 272 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundA Soluble Active Mutant of HIV-1 Integrase
Jenkins, T. M., Engelman, A., Ghirlando, R., & Craigie, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7712 · Cited by 271 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundVink, C., Groeneger, A. A. M. O., & Plasterk, R. H. A. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.6.1419 · Cited by 264 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundThe N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies
Mogk, A., Schmidt, R., & Bukau, B. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.02.001 · Cited by 263
Engelman, A., Hickman, A. B., & Craigie, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5911-5917.1994 · Cited by 244 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundThe DNA-binding domain of HIV-1 integrase has an SH3-like fold
Eijkelenboom, A. P. A. M., Puras Lutzke, R. A., Boelens, R., Plasterk, R. H. A., Kaptein, R., & Hård, K. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0995-807 · Cited by 241 · cited 2×
“Of note is the presence of an SH3-like structural motif (amino acids 220 to 270) within this domain; the folding topology of the monomeric unit is a five-stranded beta-barrel existing in solution as an isolated homodimer (23, 24).”
BackgroundIntegrase and integration: biochemical activities of HIV-1 integrase
Delelis, O., Carayon, K., Saïb, A., Deprez, E., & Mouscadet, J.-F. (2008) · Retrovirology · doi:10.1186/1742-4690-5-114 · Cited by 233 · cited 1×
“The biochemical mechanisms that lead to retroviral integration, which have been extensively studied in vitro, are defined by two catalytically related and sequentially dependent steps (18) which may be distinguished by their respective sensitivities to current inhibitors of IN function (39).”
BackgroundRetroviral DNA integration: reaction pathway and critical intermediates
Li, M., Mizuuchi, M., Burke, T. R., & Craigie, R. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601005 · Cited by 233 · cited 2×
“Some biochemical evidence does suggest that processing might in fact occur in tetrameric assemblies of IN (48).”
BackgroundLeavitt, A. D., Robles, G., Alesandro, N., & Varmus, H. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.721-728.1996 · Cited by 232 · cited 1×
“Mutation of any of these residues abrogates the catalytic functions of IN both in vitro (21, 26, 46, 72) and in the context of viral replication (27, 47, 78), and the mutant viruses thus elicited are characterized as paradigmatic class I mutants.”
BackgroundJenkins, T. M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6849 · Cited by 232 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundComplementation between HIV integrase proteins mutated in different domains.
van Gent, D. C., Vink, C., Groeneger, A. A., & Plasterk, R. H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05995.x · Cited by 231
Luo, K., Wang, T., Liu, B., Tian, C., Xiao, Z., Kappes, J., & Yu, X.-F. (2007) · Journal of Virology · doi:10.1128/jvi.02584-06 · Cited by 223 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundWu, X., Liu, H., Xiao, H., Conway, J. A., Hehl, E., Kalpana, G. V., Prasad, V., & Kappes, J. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2126-2135.1999 · Cited by 207 · cited 1×
“Reports also highlight a direct and apparently functional interaction between IN and reverse transcriptase (RT) (40, 69, 77, 79, 82), with recent evidence suggesting that this association is mediated through the CTD (40, 77).”
BackgroundDrelich, M., Wilhelm, R., & Mous, J. (1992) · Virology · doi:10.1016/0042-6822(92)90499-f · Cited by 205 · cited 1×
“Mutation of any of these residues abrogates the catalytic functions of IN both in vitro (21, 26, 46, 72) and in the context of viral replication (27, 47, 78), and the mutant viruses thus elicited are characterized as paradigmatic class I mutants.”
BackgroundMutational analysis of the integrase protein of human immunodeficiency virus type 2.
van Gent, D. C., Groeneger, A. A., & Plasterk, R. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9598 · Cited by 205 · cited 1×
“Mutation of any of these residues abrogates the catalytic functions of IN both in vitro (21, 26, 46, 72) and in the context of viral replication (27, 47, 78), and the mutant viruses thus elicited are characterized as paradigmatic class I mutants.”
BackgroundStructure-based modeling of the functional HIV-1 intasome and its inhibition
Krishnan, L., Li, X., Naraharisetty, H. L., Hare, S., Cherepanov, P., & Engelman, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002346107 · Cited by 191 · cited 1×
“Though PFV and HIV-1 are divergent members of the retroviral family lineage, HIV-1 strand transfer inhibitors also inhibit PFV IN (37), suggesting that similar catalytic mechanisms are employed by these INs (13, 36, 45).”
BackgroundAcetylation of HIV‐1 integrase by p300 regulates viral integration
Cereseto, A., Manganaro, L., Gutierrez, M. I., Terreni, M., Fittipaldi, A., Lusic, M., Marcello, A., & Giacca, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600770 · Cited by 181 · cited 3×
“The addition of a single amino acid at residue 273, an invariant residue subject to acetylation (10, 70) and possibly ubiquitinylation (61), is sufficient to significantly rescue integration activity (Table 1).”
BackgroundHIV-1 integrase crosslinked oligomers are active in vitro
Faure, A. L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki241 · Cited by 181 · cited 1×
“HIV-1 IN forms dimers and tetramers in solution, and it has been demonstrated that 3 processing is conducted by an IN dimer (30, 34).”
BackgroundCharacterization of the minimal DNA-binding domain of the HIV integrase protein
Puras Lutzke, R. A., Vink, C., & Plasterk, R. H. A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.20.4125 · Cited by 179 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundIn Vivo Analysis of Retroviral Integrase Structure and Function
Engelman, A. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60309-7 · Cited by 176
Burke, C. J., Sanyal, G., Bruner, M. W., Ryan, J. A., LaFemina, R. L., Robbins, H. L., Zeft, A. S., Middaugh, C. R., & Cordingley, M. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50138-7 · Cited by 171 · cited 1×
“The N-terminal domain (NTD) encompasses residues 1 to 50 and contains a conserved HHCC zinc finger motif that has been demonstrated in vitro to coordinate zinc ions (7, 81).”
BackgroundZhu, K., Dobard, C., & Chow, S. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5045-5055.2004 · Cited by 159 · cited 1×
“Reports also highlight a direct and apparently functional interaction between IN and reverse transcriptase (RT) (40, 69, 77, 79, 82), with recent evidence suggesting that this association is mediated through the CTD (40, 77).”
BackgroundMasuda, T., Planelles, V, Krogstad, P., & Chen, I. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6687-6696.1995 · Cited by 154
Heuer, T. S., & Brown, P. O. (1998) · Biochemistry · doi:10.1021/bi972949c · Cited by 148 · cited 1×
“Cross-linking (32, 42) and complementation (25, 73) studies of HIV-1 IN support a model in which the CTD of one subunit (analogous to the unresolved CTD of an outer PFV intasome subunit) binds subterminal viral LTR DNA, stabilizing the viral DNA terminus in the active site of the opposing subunit (the inner PFV intaso…”
BackgroundRelationship between the Oligomeric Status of HIV-1 Integrase on DNA and Enzymatic Activity
Guiot, E., Carayon, K., Delelis, O., Simon, F., Tauc, P., Zubin, E., Gottikh, M., Mouscadet, J.-F., Brochon, J.-C., & Deprez, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602198200 · Cited by 145 · cited 1×
“HIV-1 IN forms dimers and tetramers in solution, and it has been demonstrated that 3 processing is conducted by an IN dimer (30, 34).”
BackgroundGao, K., Butler, S. L., & Bushman, F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3565 · Cited by 137 · cited 1×
“Cross-linking (32, 42) and complementation (25, 73) studies of HIV-1 IN support a model in which the CTD of one subunit (analogous to the unresolved CTD of an outer PFV intasome subunit) binds subterminal viral LTR DNA, stabilizing the viral DNA terminus in the active site of the opposing subunit (the inner PFV intaso…”
BackgroundHeuer, T. S., & Brown, P. O. (1997) · Biochemistry · doi:10.1021/bi970782h · Cited by 135 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundTsurutani, N., Kubo, M., Maeda, Y., Ohashi, T., Yamamoto, N., Kannagi, M., & Masuda, T. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4795-4806.2000 · Cited by 128
Lutzke, R. A. P., & Plasterk, R. H. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4841-4848.1998 · Cited by 123 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundAo, Z., Huang, G., Yao, H., Xu, Z., Labine, M., Cochrane, A. W., & Yao, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610546200 · Cited by 119 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundInteraction between Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Integrase Proteins
Hehl, E. A., Joshi, P., Kalpana, G. V., & Prasad, V. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5056-5067.2004 · Cited by 117 · cited 1×
“Reports also highlight a direct and apparently functional interaction between IN and reverse transcriptase (RT) (40, 69, 77, 79, 82), with recent evidence suggesting that this association is mediated through the CTD (40, 77).”
BackgroundBukovsky, A., & Göttlinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6820-6825.1996 · Cited by 111 · cited 3×
“class II mutant (6) possessing a gross deletion of the entire IN region ( IN) (Fig.”
BackgroundInfluentialComplementation of integrase function in HIV‐1 virions
Fletcher, T., Soares, M. A., McPhearson, S., Hui, H., Wiskerchen, M., Muesing, M. A., Shaw, G. M., Leavitt, A. D., Boeke, J. D., & Hahn, B. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.5123 · Cited by 109 · cited 1×
“Evidence for a three-domain structural model of HIV-1 IN has been corroborated via several methodologies, including comparison of retroelement phylogeny (26), limited proteolysis (26), intragenic complementation studies (25, 31, 73), and structural data (8, 12, 22–24, 33, 51, 73, 76).”
MethodSelf-citationMousnier, A., Kubat, N. J., Massias-Simon, A., Ségéral, E., Rain, J., Bénarous, R., Emiliani, S., & Dargemont, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705162104 · Cited by 108
Low, A., Prada, N., Topper, M. B., Vaida, F., Castor, D., Mohri, H., Hazuda, D. J., Muesing, M. A., & Markowitz, M. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00397-09 · Cited by 101 · cited 1×
“also reconstructed into pR7/3(X/S)Bsd (52, 70), an env proviral derivative in”
BackgroundSelf-citationDegradation of HIV-1 Integrase by the N-end Rule Pathway
Mulder, L. C. F., & Muesing, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004670200 · Cited by 92 · cited 2×
“Modification by polyubiquitin addition is required for manifestation of the exquisite sensitivity of HIV-1 IN to proteasomal degradation (64, 68).”
BackgroundSelf-citationA Metal-induced Conformational Change and Activation of HIV-1 Integrase
Asante‐Appiah, E., & Skalka, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16196 · Cited by 91 · cited 1×
“There is evidence to suggest that the IN CTD exhibits conformational flexibility and undergoes a detectable structural rearrangement during both CCD-coordinated divalent metal binding (discriminating monoclonal antibody reactivity) (3, 4) and DNA binding (subunit-specific protein footprinting) (80).”
BackgroundInteraction of HIV-1 Integrase with DNA Repair Protein hRad18
Mulder, L. C. F., Chakrabarti, L. A., & Muesing, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203061200 · Cited by 85 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundSelf-citationViolot, S., Hong, S. S., Rakotobe, D., Petit, C., Gay, B., Moreau, K., Billaud, G., Priet, S., Sire, J., Schwartz, O., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12507-12522.2003 · Cited by 80 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundRefined solution structure of the c-terminal DNA-binding domain of human immunovirus-1 integrase
Eijkelenboom, A. P. A. M., Sprangers, R., H�rd, K., Puras Lutzke, R. A., Plasterk, R. H. A., Boelens, R., & Kaptein, R. (1999) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(19990901)36:4<556::aid-prot18>3.0.co;2-6 · Cited by 80
Lu, R., Ghory, H. Z., & Engelman, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10356-10368.2005 · Cited by 78 · cited 2×
“This analysis revealed that an overwhelming majority of the generated mutants had a class II phenotype (53).”
BackgroundIdentifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase
Wilkinson, T. A., Januszyk, K., Phillips, M. L., Tekeste, S. S., Zhang, M., Miller, J. T., Grice, S. F. J. L., Clubb, R., & Chow, S. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806241200 · Cited by 75 · cited 1×
“Reports also highlight a direct and apparently functional interaction between IN and reverse transcriptase (RT) (40, 69, 77, 79, 82), with recent evidence suggesting that this association is mediated through the CTD (40, 77).”
BackgroundHamamoto, S., Nishitsuji, H., Amagasa, T., Kannagi, M., & Masuda, T. (2006) · Journal of Virology · doi:10.1128/jvi.02471-05 · Cited by 71 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundDobard, C. W., Briones, M. S., & Chow, S. A. (2007) · Journal of Virology · doi:10.1128/jvi.00519-07 · Cited by 66
HIV‐1 reverse transcriptase and integrase enzymes physically interact and inhibit each other
Tasara, T., Maga, G., Hottiger, M. O., & Hübscher, U. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02945-3 · Cited by 60
Structural Determinants of Metal-induced Conformational Changes in HIV-1 Integrase
Asante‐Appiah, E., Seeholzer, S. H., & Skalka, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35078 · Cited by 54 · cited 7×
“confluent GHOST(3)X4/R5 cells were infected with 50 ng p24 per well in a”
BackgroundInfluentialTopper, M., Luo, Y., Zhadina, M., Mohammed, K., Smith, L., & Muesing, M. A. (2007) · Journal of Virology · doi:10.1128/jvi.02257-06 · Cited by 51 · cited 4×
“The addition of a single amino acid at residue 273, an invariant residue subject to acetylation (10, 70) and possibly ubiquitinylation (61), is sufficient to significantly rescue integration activity (Table 1).”
BackgroundInfluentialSelf-citationZhao, Z., McKee, C. J., Kessl, J. J., Santos, W. L., Daigle, J. E., Engelman, A., Verdine, G., & Kvaratskhelia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705241200 · Cited by 49 · cited 1×
“There is evidence to suggest that the IN CTD exhibits conformational flexibility and undergoes a detectable structural rearrangement during both CCD-coordinated divalent metal binding (discriminating monoclonal antibody reactivity) (3, 4) and DNA binding (subunit-specific protein footprinting) (80).”
BackgroundAnti-infectives Clinical progress of HIV-1 integrase inhibitors
Al-Mawsawi, L. Q., Al-Safi, R. I., & Neamati, N. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.2.213 · Cited by 48 · cited 1×
“The latter is an essential and irreversible event which is mediated by the catalytic activities of the viral integrase protein (IN), the recent target of successful chemotherapeutic intervention against HIV-1 infection (1).”
BackgroundNilsen, B. M., Haugan, I. R., Berg, K., Olsen, L., Brown, P. O., & Helland, D. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1580-1587.1996 · Cited by 46 · cited 1×
“minus of IN (6G5) (65), capsid (CA) (183-H12-5C) (14), or RT (11B7 and 33D5)”
Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase
Dar, M. J., Monel, B., Krishnan, L., Shun, M.-C., Di Nunzio, F., Helland, D. E., & Engelman, A. (2009) · Retrovirology · doi:10.1186/1742-4690-6-94 · Cited by 38 · cited 3×
“In addition, our grouping of IN 270 as a class I mutant is in discord with the class II phenotype previously reported for this particular mutant (17).”
BackgroundResultInfluentialMapping DNA‐binding sites of HIV‐1 integrase by protein footprinting
Dirac, A. M. G., & Kjems, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01932.x · Cited by 34 · cited 2×
“Though it has been suggested that the K273 residue plays a significant role in IN functionality, including specific DNA binding (19), substitution of alanine (K273A Stop) or arginine (K273R Stop) instead of the natural lysine residue in the truncated protein is nonetheless able to rescue integration capability that is…”
BackgroundCen, S., Niu, M., Saadatmand, J., Guo, F., Huang, Y., Nabel, G. J., & Kleiman, L. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.1042-1049.2004 · Cited by 34 · cited 1×
“Previous work has demonstrated that Gag-Pol can be packaged into virions independently of the N-terminal Gag domains, and thus the high levels of partially processed Gag-Pol present in the cytoplasm of IN 268-transfected cells could account for the efficient packaging of RT and IN into these mutant virions (9, 15, 49).”
BackgroundChiu, H.-C., Yao, S.-Y., & Wang, C.-T. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3221-3231.2002 · Cited by 34 · cited 1×
“Previous work has demonstrated that Gag-Pol can be packaged into virions independently of the N-terminal Gag domains, and thus the high levels of partially processed Gag-Pol present in the cytoplasm of IN 268-transfected cells could account for the efficient packaging of RT and IN into these mutant virions (9, 15, 49).”
BackgroundAm, S., Nornes, S., Haugan, I. R., Olsen, L., Prasad, V. R., Endresen, C., Goff, S. P., & De, H. (1992) · PubMed · Cited by 33
Characterization of HIV-1 integrase N-terminal mutant viruses
Lloyd, A. G., Ng, Y. S., Muesing, M. A., Simon, V. R., & Mulder, L. C. F. (2006) · Virology · doi:10.1016/j.virol.2006.10.007 · Cited by 23
Self-citationCherepanov, P. (2010) · EMBO Reports · doi:10.1038/embor.2010.58 · Cited by 19 · cited 2×
“Though PFV and HIV-1 are divergent members of the retroviral family lineage, HIV-1 strand transfer inhibitors also inhibit PFV IN (37), suggesting that similar catalytic mechanisms are employed by these INs (13, 36, 45).”
BackgroundCharacterization of the DNA-Binding Activity of HIV-1 Integrase Using a Filter Binding Assay
Haugan, I. R., Nilsen, B. M., Worland, S. T., Olsen, L., & Helland, D. E. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2843 · Cited by 18 · cited 1×
“Functions attributed to the IN CTD include enhancement of IN multimerization (43), nonspecific and, presumptively, specific DNA binding capabilities (19, 28, 29, 38, 41, 44, 55, 56, 74), and facilitation of host factor binding (2, 10, 35, 54, 63, 75).”
BackgroundIncorporation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase into Virus-Like Particles
Liao, W.-H., Huang, K.-J., Chang, Y.-F., Wang, S.-M., Tseng, Y.-T., Chiang, C.-C., Wang, J.-J., & Wang, C.-T. (2007) · Journal of Virology · doi:10.1128/jvi.01796-06 · Cited by 18 · cited 1×
“Previous work has demonstrated that Gag-Pol can be packaged into virions independently of the N-terminal Gag domains, and thus the high levels of partially processed Gag-Pol present in the cytoplasm of IN 268-transfected cells could account for the efficient packaging of RT and IN into these mutant virions (9, 15, 49).”
Background
Cited by
Exosomes Derived from HIV-1-infected Cells Contain Trans-activation Response Element RNA
Narayanan, A., Iordanskiy, S., Das, R., Van Duyne, R., Santos, S., Jaworski, E., Guendel, I., Sampey, G., Dalby, E., Iglesias-Ussel, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438895 · Cited by 316
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle
Munir, S., Thierry, S., Subra, F., Deprez, E., & Delelis, O. (2013) · Retrovirology · doi:10.1186/1742-4690-10-87 · Cited by 89
“Concerning D NAL, based on previous established strategy [21], we explored the optimal conditions for re liable quantification and further characterized the quantification of pDNA L and uDNAL, and compared the sensitivity of this approach to that of Southern blotting.”
ResultIntegrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis
Elliott, J. L., Eschbach, J. E., Koneru, P. C., Li, W., Puray-Chavez, M., Townsend, D., Lawson, D. Q., Engelman, A. N., Kvaratskhelia, M., & Kutluay, S. B. (2020) · eLife · doi:10.7554/elife.54311 · Cited by 59
HIV–host interactome revealed directly from infected cells
Luo, Y., Jacobs, E. Y., Greco, T. M., Mohammed, K., Tong, T., Keegan, S., Binley, J. Μ., Cristea, I. M., Fenyö, D., Rout, M. P., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.68 · Cited by 57
Self-citation
Metadata
- Authors
- Mohammed, K. D., Topper, M. B., & Muesing, M. A.
- Affiliations
- Aaron Diamond AIDS Research Center (US)
- Corresponding author
- Muesing, Mark A.
- ORCID
- Mohammed, Kevin D.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2011-05-15
- Volume
- 85
- Issue
- 10
- Pages
- 4654-4666
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3126176
- OpenAlex
- W2165141847
- Cited by
- 44
- References
- 84
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2022: 8 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R21AI062369, R01 AI065321, R21AI065321)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 integrase, Gag-Pol, viral integration, reverse transcription, viral infectivity, integrase multimerization, precursor protein processing
- MeSH terms
- Cell Line, Humans, Virus Replication, HIV-1, Virus Integration, Sequence Deletion, Protein Structure, Tertiary, HIV Integrase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.